PubMed COVID-19 Clinical Care

"Patient dignity can be ensured by providing adequate health care": A phenomenological analysis on survival strategies of military nurses

Wednesday, February 21, 2024 - 4:00 AM

CONCLUSIONS: The study's findings would inspire healthcare professionals to use various survival strategies when facing critical clinical situations. Additionally, this study encourages nurses to develop survival skills to avoid depression, fear, and

Chronic urticaria after Moderna COVID-19 vaccine boosters: A case series

Wednesday, February 21, 2024 - 4:00 AM

No abstract

Conducting nationwide cohort COVID-19 serology surveys on a nation with limited resources and decentralized governance: Evidence from Indonesia

Wednesday, February 21, 2024 - 4:00 AM

Knowing the level of SARS-CoV-2 transmission is crucial for decision-making on Coronavirus disease (COVID-19) handling. Guidelines for measuring SARS-CoV-2 antibodies to estimate seroprevalence are conceptually straightforward and internationally

Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine

Wednesday, February 21, 2024 - 4:00 AM

We evaluated the immunologic response to a novel vaccine regimen that included 2 doses of NVX-CoV2373 (Novavax) followed by 1 dose of BNT162b2 (Pfizer-BioNTech) monovalent booster vaccine. A durable neutralizing antibody response to Omicron BA.4/BA.5

Infectious Diseases Among People Experiencing Homelessness: A Systematic Review of the Literature in the United States and Canada, 2003-2022

Wednesday, February 21, 2024 - 4:00 AM

Homelessness increases the risk of acquiring an infectious disease. We conducted a systematic review of the literature to identify quantitative data related to infectious diseases and homelessness. We searched Google Scholar, PubMed, and SCOPUS for

Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C)

Wednesday, February 21, 2024 - 4:00 AM

CONCLUSIONS: Sotrovimab demonstrated clinical effectiveness in preventing severe outcomes (hospitalisation, mortality) in the period 27 September 2021-30 April 2022, which included Delta and Omicron BA.1 variants and an early surge of Omicron BA.2

A population level study on the determinants of COVID-19 vaccination rates at the U.S. county level

Wednesday, February 21, 2024 - 4:00 AM

Multiple COVID-19 vaccines were proven to be safe and effective in curbing severe illness, but despite vaccine availability, vaccination rates were relatively low in the United States (U.S.). To better understand factors associated with low COVID-19

The COVID-19 pandemic impact on continuity of care provision on rare brain diseases and on ataxias, dystonia and PKU. A scoping review

Wednesday, February 21, 2024 - 4:00 AM

One of the most relevant challenges for healthcare providers during the COVID- 19 pandemic has been assuring the continuity of care to patients with complex health needs such as people living with rare diseases (RDs). The COVID-19 pandemic

The mediating role of coping styles in the relationship between fear of COVID-19 and mental health problems: a cross-sectional study among nurses

Wednesday, February 21, 2024 - 4:00 AM

Fear of being infected by coronavirus disease 2019 (COVID-19) could trigger mental health problems among nurses at the frontline. In such a situation, coping strategies are needed to deal with the imminent threat. The purpose of this study was to

DeepCSFusion: Deep Compressive Sensing Fusion for Efficient COVID-19 Classification

Wednesday, February 21, 2024 - 4:00 AM

Worldwide, the COVID-19 epidemic, which started in 2019, has resulted in millions of deaths. The medical research community has widely used computer analysis of medical data during the pandemic, specifically deep learning models. Deploying models on